Sichenzia Ross Ference Carmel represented INmune Bio, Inc. in the offering.INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage immunology company, announced approximately $4.8 million registered direct offering…
INmune Bio’s $4.8 Million Common Stock Offering
![](https://globallegalchronicle.com/wp-content/uploads/2024/05/inmune-bios-4-8-million-common-stock-offering_6641c72a07b19-480x360.jpeg)